EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
FDA Drug Approval Pathways: Strategies for U.S. Pharmaceutical Companies
Getting a new medicine from the lab bench to a patients medicine cabinet is one of the longest costliest and most heavily scrutinized journeys in American business For every drug that reaches pharmacy shelves thousands of molecules never make it out of early testing The difference between the ones that succeed and the ones that stall often isnt the science alone its the regulatory strategy behind...
-
Techno Trends
FDA Authorises Aletta for Autonomous Blood Collection
The US Food and Drug Administration FDA has authorised Aletta the first standalone robotic device designed to collect blood from a patients arm without handson operator intervention
-
Projects
Cambrex Expands Milan R&D Operations With US$30 Million Investment
Cambrex has begun construction of a new research and development facility at its Profarmico Milano site in Italy supported by a US million investment The initiative is designed
-
Research Insights
Phycocyanobilin: A potential bioactive compound from Arthrospira platensis targeting LYN protein associated with systemic lupus erythematosus
Phycocyanobilin a bioactive compound derived from Arthrospira platensis C was investigated for its potential role in systemic lupus erythematosus SLE based on its structural similarity to bilirubin
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
FDA Drug Approval Pathways: Strategies for U.S. Pharmaceutical Companies
Kate Williamson
Navigating FDA drug approval requires more than strong science - it demands regulatory strategy from day one. This article breaks down the U.S. drug approval process, key FDA regulatory pathways (Fast...
-
2
Navigating the Landscape of Pharmacogenomics in Diagnosis to Drug Delivery in Cancer Therapeutics
Vikas Jhawat
Monika Gulia
In the realm of cancer therapeutics, pharmacogenomics has emerged as a critical linchpin in shaping treatment decisions. The relentless adaptability of cancer cells, often culminating in resistance to...
-
3
The Future of Drug Pricing Reforms: What Americans Need to Know
Kate Williamson
High costs of drugs have ignited legislative measures meant to bring down cost of these commodities. This is particularly the case in the U. S. Some of the key measures which have been included are Me...
-
4
ABM Pharma Tactics US: Unlocking B2B Lead Gen Success
Kate Williamson
The Account-based marketing (ABM) pharma strategies are reshaping the US B2B pharma marketing by focusing the high value accounts rather than the lead volume. Pharmaceutical account-based marketing en...
-
5
How to Build a Compliant Pharma Email Strategy Using Automation Tools
Kate Williamson
A pharma email strategy that is compliant and will be executed in a more automated manner is not only about automation, it is also about structured workflows, stringent data governance, and integrated...
press releasesRead more...
Genentech and Roche Announce Grand Opening of Boston R&D Innovation Center
Kincell Bio and Cellipont Bioservices today announced the completion of their merger to form Kincellis Advanced Therapies Kincellis a USbased contract development and manufacturing organization focused on cell therapies and other advanced modalities
Puma Biotechnology Initiates ALISCA®-Lung2, a Phase II Trial of Alisertib in Combination with Paclitaxel for the Treatment of Patients with Advanced Small Cell Lung Cancer
Puma Biotechnology Inc NASDAQ PBYI a biopharmaceutical company announced the initiation of its ALISertib in CAncer ALISCALung Phase II trial PUMAALI NCT of alisertib
OncoC4 Receives FDA Fast Track Designation for Cesalatamig, an Investigational PD-1/VEGF Bispecific Antibody
OncoC Inc a late clinicalstage biopharmaceutical company developing novel medicines for cancer and neurodegenerative diseases today announced that the US FDA has granted Fast Track Designation
Mission Bio Launches Tapestri® Triomics for Simultaneous DNA, RNA, and Protein Analysis at Single-Cell Resolution
Mission Bio a leader in singlecell multiomics today announced Tapestri Triomics a new expansion of the Tapestri Platform that simultaneously analyzes DNA RNA and protein in the same cell By connecting genotype
Events Read more...
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality
Illume Hotel Taipei, Taiwan
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
28 - 02
Sep 2026Discovery on Target 2026
Boston, MA, USA
29 - 01
Sep 202610th IPF Summit 2026
Boston, MA, USA
29 - 01
Sep 2026Powtech Technopharm 2026
Nuremberg, Germany
30 - 01
Sep 2026Pharma Launch Excellence Summit
Hyatt Regency Boston Harbor, B...
LATEST NEWSRead more...
Bayer’s KERENDIA Receives FDA Approval for Chronic Kidney Disease Linked to Type 1 Diabetes
Bayers KERENDIA finerenone has received approval from the US Food and Drug Administration FDA for use in adults with chronic kidney disease CKD associated with type diabetes TD
Kincell Bio and Cellipont Bioservices Merge to Create Kincellis Advanced Therapies
Kincell Bio and Cellipont Bioservices have merged to form Kincellis Advanced Therapies creating a broader contract development and manufacturing organisation CDMO focused on advanced cell and gene therapies
ProBio and Kun Tuo collaborate on integrated CDMO-CRO solutions for advanced therapies
ProBio has entered into a strategic collaboration with Kun Tuo an IQVIA company and clinical research organisation CRO in China to support biopharmaceutical companies developing advanced therapies in the Chinese market
DifGen Pharmaceuticals receives FDA approval for epinephrine injection
DifGen Pharmaceuticals has received approval from the US Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for Epinephrine Injection USP mgmL in singledose vials
VaxThera and Codagenix partner to advance next-generation yellow fever vaccine
VaxThera SAS a Colombian biotechnology company developing and manufacturing vaccines and biological products has entered into an agreement with Codagenix Inc to exclusively license
BostonGene expands collaboration with Dana-Farber to advance breast cancer research
BostonGene has expanded its scientific collaboration with DanaFarber Cancer Institute to study the biological mechanisms involved in BRCA and BRCAassociated breast cancers
